scispace - formally typeset
S

Seung Il Kim

Researcher at University of Ulsan

Publications -  72
Citations -  3694

Seung Il Kim is an academic researcher from University of Ulsan. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 29, co-authored 72 publications receiving 3109 citations. Previous affiliations of Seung Il Kim include University Health System & Yonsei University.

Papers
More filters
Journal ArticleDOI

Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP)

Hui Sung Moon, +6 more
- 28 Feb 2011 - 
TL;DR: The development of a microfluidic device for the separation of CTCs from blood cells based on the physical properties of cells and the serial combination of these two different sorting techniques enabled high-speed continuous flow-through separation without labeling is presented.
Journal ArticleDOI

Microbiota-Derived Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial Development

Yong-Soo Lee, +16 more
- 12 Dec 2018 - 
TL;DR: It is demonstrated that LAB-type symbiont-derived lactate plays a pivotal role in promoting ISC-mediated epithelial development in a Gpr81-dependent manner and protected mice in response to gut injury provoked by combined treatments with radiation and chemotherapy drug.
Journal ArticleDOI

Poor Outcome of Hormone Receptor–Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea—A Report From the Korean Breast Cancer Society

Sei Hyun Ahn, +6 more
- 10 Jun 2007 - 
TL;DR: Younger patients (age < 35) showed worse prognosis than older patients ( age, 35 to 50 years) only in the hormone receptor-unknown or hormone receptors-positive subgroups, and adjuvant tamoxifen therapy might provide less survival benefit when added to chemotherapy in very young breast cancer patients.
Journal ArticleDOI

Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry

Seho Park, +7 more
- 01 Feb 2012 - 
TL;DR: Molecular subtypes using four biomarkers could provide clinically useful information of tumor biology and clinical behaviors, and could be used for determining treatment and surveillance strategies.
Journal ArticleDOI

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers

Seho Park, +7 more
- 01 Aug 2011 - 
TL;DR: The results suggest that AR could be an additional marker for endocrine responsiveness in ER-positive cancers and a candidate for therapeutic targeting of ER-negative tumors.